Lista de obras -

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

artículo científico publicado en 2009

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

artículo científico publicado en 2014

ACE polymorphism and response to electroconvulsive therapy in major depression

artículo científico publicado en 2009

Anxiety Disorders and Temperament-an Update Review

artículo científico publicado en 2017

Apolipoprotein E polymorphism is associated with age of onset in schizophrenia

artículo científico publicado en 2004

Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach

artículo científico publicado en 2007

Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia

scientific article published on 14 September 2006

Association of EGF polymorphism with schizophrenia in Finnish men.

artículo científico publicado en 2004

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

artículo científico publicado en 2018

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

artículo científico publicado en 2018

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

artículo científico publicado en 2013

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2007

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

artículo científico publicado en 2014

Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring

artículo científico publicado en 2003

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy

artículo científico publicado en 2007

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia

artículo científico publicado en 2003

Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia

scientific article published on 01 June 2007

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

artículo científico publicado en 2010

Change in antipsychotic usage pattern and risk of relapse in older patients with schizophrenia

artículo científico publicado en 2013

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

artículo científico publicado en 2005

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

artículo científico publicado en 2014

Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders

artículo científico publicado en 2012

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy

artículo científico publicado en 2008

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia

artículo científico publicado en 2003

Duloxetine Eli Lilly.

artículo científico publicado en 2002

Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal

artículo científico publicado en 2005

Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study

artículo científico publicado en 2013

Elderly patients with major depressive disorder and delusional disorder are at increased risk of subsequent dementia

artículo científico publicado en 2004

Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein

artículo científico publicado en 2010

Electroconvulsive therapy in patients with depression and fibromyalgia

scientific article published on 01 August 2004

Factors associated with subjective side-effects during clozapine treatment

artículo científico publicado en 2014

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

artículo científico publicado en 2018

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

artículo científico publicado en 2017

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

scientific article published on 01 March 2008

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics

artículo científico publicado en 2004

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics

artículo científico publicado en 2003

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

artículo científico publicado en 2011

Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia

artículo científico publicado en 2004

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

artículo científico publicado en 2010

Meta-analysis of anxiety disorders and temperament

artículo científico publicado en 2014

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia

artículo científico publicado en 2003

Neuregulin genotype and medication response in Finnish patients with schizophrenia

scientific article published on 01 November 2004

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

artículo científico publicado en 2013

One-year follow-up after discontinuing maintenance electroconvulsive therapy

artículo científico publicado en 2012

One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants

artículo científico publicado en 2004

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

artículo científico publicado en 2011

Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia

artículo científico publicado en 2014

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

artículo científico publicado en 2014

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis

artículo científico publicado en 2015

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2008

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

SERT and NET polymorphisms, temperament and antidepressant response

artículo científico publicado en 2015

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

artículo científico publicado en 2015

Smoking and weight among patients using clozapine

artículo científico publicado en 2014

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

artículo científico publicado en 2009

TPH1 A218C polymorphism and temperament in major depression

artículo científico publicado en 2013

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

artículo científico publicado en 2009

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

artículo científico publicado en 2016

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

artículo científico publicado en 2010

The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight

artículo científico publicado en 2017

The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2005

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

article

The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study

artículo científico publicado en 2007

Use of antipsychotic medications in older home-care patients. Report from nine European countries.

artículo científico publicado en 2008

Use of antipsychotics in older home care patients in Finland

artículo científico publicado en 2008

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

artículo científico publicado en 2010

[Diagnosis and drug therapy of anxiety disorders in primary health care]

artículo científico publicado en 2015

[Is antipsychotic drug therapy predictable?]

artículo científico publicado en 2005

Lista de obras de

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

ACE polymorphism and response to electroconvulsive therapy in major depression

Anxiety Disorders and Temperament-an Update Review

Apolipoprotein E polymorphism is associated with age of onset in schizophrenia

Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach

Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia

Association of EGF polymorphism with schizophrenia in Finnish men.

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia

Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

Change in antipsychotic usage pattern and risk of relapse in older patients with schizophrenia

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia

Duloxetine Eli Lilly.

Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal

Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study

Elderly patients with major depressive disorder and delusional disorder are at increased risk of subsequent dementia

Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein

Electroconvulsive therapy in patients with depression and fibromyalgia

Factors associated with subjective side-effects during clozapine treatment

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

Meta-analysis of anxiety disorders and temperament

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia

Neuregulin genotype and medication response in Finnish patients with schizophrenia

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

One-year follow-up after discontinuing maintenance electroconvulsive therapy

One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

SERT and NET polymorphisms, temperament and antidepressant response

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

Smoking and weight among patients using clozapine

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

TPH1 A218C polymorphism and temperament in major depression

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight

The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study

Use of antipsychotic medications in older home-care patients. Report from nine European countries.

Use of antipsychotics in older home care patients in Finland

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

[Diagnosis and drug therapy of anxiety disorders in primary health care]

[Is antipsychotic drug therapy predictable?]